These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7807174)

  • 1. Neurotoxicity and pharmacokinetics of ventriculolumbar perfusion of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in dogs.
    Kochi M; Takaki S; Kuratsu J; Seto H; Kitamura I; Ushio Y
    J Neurooncol; 1994; 19(3):239-44. PubMed ID: 7807174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxicity and pharmacokinetics of intrathecal perfusion of ACNU in dogs.
    Kochi M; Kuratsu J; Mihara Y; Takaki S; Inoue N; Sueyoshi N; Uemura S; Ushio Y
    Cancer Res; 1990 May; 50(10):3119-23. PubMed ID: 2334907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intrathecal perfusion of ACNU neurotoxicity and intrathecal pharmacokinetics in dogs].
    Kochi M; Kuratsu J; Mihara Y; Inoue N; Takaki S; Sueyoshi N; Soyama N; Uemura S; Ushio Y
    No Shinkei Geka; 1989 Aug; 17(8):741-6. PubMed ID: 2586715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxicity of local administration of two nitrosoureas in malignant gliomas.
    Yamashima T; Yamashita J; Shoin K
    Neurosurgery; 1990 May; 26(5):794-9. PubMed ID: 2352597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S; Tashiro T; Ogawa M
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
    Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
    Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial treatment with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in a patient with primary myelofibrosis.
    Asano Y; Shimokawa M; Okabe H; Sanefuji H; Kato K
    Acta Haematol; 1991; 85(2):103-4. PubMed ID: 2024552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of intrathecally administered ACNU in mongrel dogs: pharmacokinetics and quantitative autoradiographic study.
    Hori T; Tanaka S; Nishiyama M; Kamitani H; Watanabe T; Tabuchi F; Tatsuhara T; Nakajima E
    Surg Neurol; 1993 Sep; 40(3):183-95. PubMed ID: 8346472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
    Higuchi A; Miyazaki T; Sakurada K; Morioka M; Musashi M; Imamura M; Maekawa I; Saitoh H; Ohtani N; Kasai M
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1253-9. PubMed ID: 3859250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitro soureas and other nitrosoureas in beagles.
    Levin VA; Byrd D; Campbell J; Giannini DD; Borcich JK; Davis RL
    Cancer Res; 1985 Aug; 45(8):3803-9. PubMed ID: 3860287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Randomized controlled study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in comparison with busulfan for chronic myelogenous leukemia].
    Masaoka T; Kimura K; Miyazaki T; Hirota Y; Nakamura T; Yasunaga K; Ohkubo H; Okamoto Y; Fujitake H; Kitani T
    Gan To Kagaku Ryoho; 1985 May; 12(5):1111-8. PubMed ID: 3888116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the nitrosourea anti-tumor chemotherapeutical agent MCNU on five human myeloma cell lines.
    Otsuki T; Sakaguchi H; Yamada O; Yawata Y; Ueki A
    Oncol Rep; 1998; 5(4):827-32. PubMed ID: 9625826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.
    Tonn JC; Schönmayr R; Kraemer HP
    J Neurooncol; 1990 Feb; 8(1):41-5. PubMed ID: 2319289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase I study on oral administration of methyl-6-[[[(2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Kanamaru A; Nagai K; Fujita S; Masaoka T; Takubo T; Kitani T; Taniguchi N; Horiuchi A; Tsubaki K; Kawagoe H; Hirata M; Yonezawa T; Tsubakio T; Yasunaga K; Okamoto Y; Fujitake H; Ohkubo A
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1831-7. PubMed ID: 6882006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Discriminant analysis of bone marrow suppression of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Saito A; Oride M; Munaka M; Uozumi T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):511-5. PubMed ID: 3813579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
    Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic activity of MCNU: a new antitumor agent.
    Sekido S; Ninomiya K; Iwasaki M
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Tanaka I; Kobayashi T; Shirakawa S; Ikeda Y; Kobayashi M; Yamagata K; Ohta K; Ohno R; Yamada H; Yamada K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new nitrosourea derivative for the treatment of chronic myelogenous leukemia.
    Hiraoka A; Masaoka T; Shibata H; Miyazaki T; Nakamura T; Yasunaga K; Kitani T; Yonezawa T; Kawagoe H; Horiuchi A
    Leuk Res; 1988; 12(6):487-90. PubMed ID: 3043111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].
    Sekido S; Ninomiya K; Araki T; Ueno M; Kinbara M
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1492-500. PubMed ID: 6234861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.